ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

MRI Effective For Women With BRCA Gene Mutations

September 24, 2004

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997

Scientific Program Organized For XIIIth Cancer Congress

October 2, 1981

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995